Skip to content

Effect of oxycodone on immune function and inflammatory factors after laparoscopic colorectal tumor resection

Effect of oxycodone postoperative analgesia on postoperative immune function in patients with laparoscopic colorectal tumor resection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400089072
Enrollment
Unknown
Registered
2024-09-01
Start date
2024-09-01
Completion date
Unknown
Last updated
2024-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal neoplasia

Interventions

The oxycodone group:Postoperative administration of oxycodone PCIA pump(1mg/ml)
The Sufentanil group:Postoperative administration of sufentanil PCIA pump(1ug /ml)

Sponsors

Huazhong University of Science and Technology Union Shenzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 18 years = age =60 years; Not limited to men and women, nationality; General anesthesia surgery, the expected operation time is more than 2 hours, and the operation end time is before 12:00pm; Solicit comments from patients or their families and agree to participate in this trial.

Exclusion criteria

Exclusion criteria: He was admitted to ICU directly after surgery. Pregnancy or lactation; Had a solid organ or bone marrow transplant; Diseases that may affect immune-related indicators, such as autoimmune diseases such as rheumatoid arthritis and SLE or malignant hematological tumors (leukemias and lymphomas, etc.); Acute brain injury (traumatic brain injury, subarachnoid hemorrhage, acute ischemic stroke, acute intracranial hemorrhage, acute intracranial infection); Chronic kidney disease; Acute myocardial infarction or severe heart failure (NYHA: Level 4); Severe chronic liver disease (Child-Pugh: Grade C); Deafness, aphasia, mental illness or severe cognitive impairment; Tracheal catheter was removed within 24 hours after operation. Unwillingness or unwillingness to provide informed consent or poor compliance.

Design outcomes

Primary

MeasureTime frame
Cytokines and lymphocyte subsets;

Secondary

MeasureTime frame
VAS scores;Subjective sleep rating;

Countries

China

Contacts

Public ContactChunmei Lin

Huazhong University of Science and Technology Union Shenzhen Hospital

819682320@qq.com+86 7558217916

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026